

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking result

In this article, we explore the basics of buffer ETFs and share our thoughts on why we think these ETFs could be a powerful tool for managing risk. By selecting a buffer ETF with a predefined payoff profile that best matches one's preferences, one can achieve the equivalent of a customized option strategy to position for a pullback. The ideal scenario for using buffer ETFs would be when the market has performed exceptionally well and is at risk of a potential pullback.

Greetings, VettaFi Voices! In recent months, we've talked about a lot of different issues, from the micro to the macro, but let's go REALLY big picture this week.
SEC filings for BSEP aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.